DNA Damage Response and Oncogenic Signaling
DNA 损伤反应和致癌信号
基本信息
- 批准号:10332432
- 负责人:
- 金额:$ 23.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-14 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Increases in cancer incidence and rising cancer costs highlight the need to advance cancer biology through the
growth of a well-trained workforce. Almost all human cancers have alterations in signaling pathways associated
with DNA damage response and oncogenic signaling, and such pathways are also the focus of targeted therapies
already in the clinic and under development. To train the next generation of cancer researchers, we have
developed an institution-wide cancer biology training program for postdoctoral fellows focused on this area of
cancer research, called the DNADRS program. This program is housed at the City of Hope, an NCI-designated
Comprehensive Cancer Center, which is known internationally for clinical cancer research and has an
outstanding record of basic cancer research. This T32 program began in 2016, and this is the first renewal
application. The 3 T32-supported postdoctoral trainees supported for up to 3 years are selected for the DNADRS
program through a rigorous process, including a personal interview. Each trainee establishes a mentoring
committee that includes a physician to foster cross-pollination of ideas between the basic and translational
aspects of cancer research. Annual reappointment is based on annual written reports from the trainee and
mentoring committee. As part of a recruitment incentive in the DNADRS program, City of Hope will continue to
provide an additional postdoctoral trainee position for every underrepresented minority trainee recruited, up to a
total of 6 positions. Furthermore, to attract the best postdoctoral candidates at a national level, City of Hope
continues to commit to salary supplementation for all DNADRS trainees, a stipend for research supplies, and full
administrative and faculty salary support. Trainees will be mentored by 18 faculty members, all of whom are
performing cancer-focused high-impact research and have a history of mentoring postdoctoral fellows. To
enhance their chances of developing into independent cancer researchers, all DNADRS trainees take a unique
common curriculum that provides a continuum of learning including scientific coursework that includes ethical
conduct of research and proper research design, as well as professional development courses. In addition,
trainees participate in cutting-edge research programs, journal clubs, seminars, symposiums, regular luncheons
with mentors, mentoring committee meetings, national and international scientific conferences, and finally a
yearly DNADRS Symposium. The stellar and comprehensive Shared Resource Facilities associated with the
Cancer Center provide training in state-of the art technologies. The request for funding to renew this research
training grant is justified by our track-record from the last funding cycle of seven successful trainees that include
three underrepresented minority fellows, the relevance of the research training to cancer, the experience of the
mentors, the outstanding commitment of City of Hope, and the diverse population of the geographical area
served by our institution.
项目摘要
癌症发病率的增加和癌症成本的上升突显了通过
训练有素的劳动力的增长。几乎所有的人类癌症都有相关信号通路的改变
与DNA损伤反应和致癌信号有关,这些通路也是靶向治疗的重点
已经在临床上,并正在开发中。为了培养下一代癌症研究人员,我们有
为博士后研究员制定了一个机构范围的癌症生物学培训计划,重点是这一领域
癌症研究,称为DNADRS计划。这个项目设在希望之城,一个由NCI指定的
综合性癌症中心,以临床癌症研究而闻名国际,拥有
杰出的癌症基础研究记录。这项T32计划始于2016年,这是第一次续签
申请。3名T32资助的博士后实习生最多支持3年,被选为DNADRS
计划通过一个严格的过程,包括个人面试。每个实习生都建立了一个指导
该委员会包括一名内科医生,以促进基础和翻译之间的思想交叉授粉
癌症研究的各个方面。年度续聘是基于受训人员的年度书面报告和
指导委员会。作为DNADRS计划招募激励的一部分,希望之城将继续
为每个招聘的代表不足的少数族裔实习生提供一个额外的博士后实习生职位,最高可达
总共有6个职位。此外,为了吸引国家一级最好的博士后候选人,希望之城
继续承诺为所有DNADRS实习生提供工资补充,为研究用品提供津贴,并
行政和教职员工工资支持。学员将由18名教职员工指导,他们都是
从事以癌症为重点的高影响力研究,并有指导博士后研究员的历史。至
提高他们发展成为独立癌症研究人员的机会,所有DNADRS实习生都采取了独特的
提供连续学习的公共课程,包括包括伦理道德在内的科学课程
进行研究和适当的研究设计,以及专业发展课程。此外,
学员参加前沿研究项目、期刊俱乐部、研讨会、座谈会、定期午餐会
与导师、指导委员会会议、国内和国际科学会议,以及最后一个
DNADRS年度研讨会。一流且全面的共享资源设施与
癌症中心提供最先进的技术培训。更新这项研究的资金申请
培训赠款是根据我们上一个资助周期的七名成功学员的记录来证明的,这些学员包括
三名代表不足的少数族裔研究员,研究培训与癌症的相关性,
导师,希望之城的杰出承诺,以及地理区域的多样化人口
由我们机构提供服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BINGHUI SHEN其他文献
BINGHUI SHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BINGHUI SHEN', 18)}}的其他基金
Okazaki fragment maturation: mutagenesis and cell survival
冈崎片段成熟:诱变和细胞存活
- 批准号:
10636417 - 财政年份:2023
- 资助金额:
$ 23.37万 - 项目类别:
DNA repair gene mutations and prostate cancer
DNA修复基因突变与前列腺癌
- 批准号:
10307594 - 财政年份:2019
- 资助金额:
$ 23.37万 - 项目类别:
DNA repair gene mutations and prostate cancer
DNA修复基因突变与前列腺癌
- 批准号:
10064136 - 财政年份:2019
- 资助金额:
$ 23.37万 - 项目类别:
DNA repair gene mutations and prostate cancer
DNA修复基因突变与前列腺癌
- 批准号:
10529297 - 财政年份:2019
- 资助金额:
$ 23.37万 - 项目类别:
Lung and other cancer etiological model of BER gene polymorphisms
BER基因多态性的肺癌和其他癌症病因模型
- 批准号:
8103282 - 财政年份:2010
- 资助金额:
$ 23.37万 - 项目类别:
Lung and other cancer etiological model of BER gene polymorphisms
BER基因多态性的肺癌和其他癌症病因模型
- 批准号:
7990964 - 财政年份:2010
- 资助金额:
$ 23.37万 - 项目类别:
Role of Nucleases in RNA Primer Removal and Mutagenesis
核酸酶在 RNA 引物去除和诱变中的作用
- 批准号:
7809910 - 财政年份:2009
- 资助金额:
$ 23.37万 - 项目类别:
MECHANISTIC ANALYSIS OF SITE DIRECTED MUTANT NUCLEASE ENZYMES
定点突变核酸酶的机理分析
- 批准号:
6470648 - 财政年份:2001
- 资助金额:
$ 23.37万 - 项目类别:
相似海外基金
Molecular mechanism of the lipid raft-based oncogenic signal transduction
基于脂筏的致癌信号转导的分子机制
- 批准号:
26830071 - 财政年份:2014
- 资助金额:
$ 23.37万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Oncogenic KRAS-mediated signal transduction and regulatory mechanisms for developing therapeutic strategies against lung adenocarcinoma
致癌 KRAS 介导的信号转导和调控机制,用于制定肺腺癌治疗策略
- 批准号:
26461181 - 财政年份:2014
- 资助金额:
$ 23.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel therapeutic strategies in gliomas, based on the inhibition of the oncogenic signal transduction pathways Pim-1 / STAT3 through RNA interference and miRNA replacement
神经胶质瘤的新治疗策略,基于通过 RNA 干扰和 miRNA 替代抑制致癌信号转导途径 Pim-1 / STAT3
- 批准号:
249229082 - 财政年份:2014
- 资助金额:
$ 23.37万 - 项目类别:
Research Grants
Study on functional significance of transcription factor GATA-6during oncogenic signal transduction
转录因子GATA-6在致癌信号转导过程中的功能意义研究
- 批准号:
22501007 - 财政年份:2010
- 资助金额:
$ 23.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of oncogenic signal transduction pathways by inositol polyphosphates
肌醇多磷酸对致癌信号转导途径的调节
- 批准号:
8131897 - 财政年份:2008
- 资助金额:
$ 23.37万 - 项目类别:
Regulation of oncogenic signal transduction pathways by inositol polyphosphates
肌醇多磷酸对致癌信号转导途径的调节
- 批准号:
7513660 - 财政年份:2008
- 资助金额:
$ 23.37万 - 项目类别:
Regulation of oncogenic signal transduction pathways by inositol polyphosphates
肌醇多磷酸对致癌信号转导途径的调节
- 批准号:
8094509 - 财政年份:2008
- 资助金额:
$ 23.37万 - 项目类别:
Regulation of oncogenic signal transduction pathways by inositol polyphosphates
肌醇多磷酸对致癌信号转导途径的调节
- 批准号:
7917064 - 财政年份:2008
- 资助金额:
$ 23.37万 - 项目类别:
Analysis of oncogenic signal transduction and target genes by constitutive active mutations of c-Kit and Flt3
c-Kit和Flt3组成型活性突变分析致癌信号转导和靶基因
- 批准号:
14570977 - 财政年份:2002
- 资助金额:
$ 23.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ONCOGENIC SIGNAL TRANSDUCTION & THE RAS GAP SH3 DOMAIN
致癌信号转导
- 批准号:
2397396 - 财政年份:1996
- 资助金额:
$ 23.37万 - 项目类别:














{{item.name}}会员




